My Portfolio
My Watchlists
Profile & Performance
Smart Portfolio
Find & Follow Experts
Top Lists
Top Experts
Make Better, Data Driven Investment Decisions
TipRanks tools are all you need to make data-driven investment decisions, conduct comprehensive stock research, find new investment ideas, analyze your portfolio, and follow the best-performing Wall Street experts.
About Us
Plans & Pricing
Celldex Therapeutics Inc (CLDX)
NASDAQ:CLDX
CLDX nasdaq
United States
Celldex

Celldex Stock Analysis & Ratings

Celldex Stock Analysis Overview

Smart Score
10
Outperform
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
The Celldex stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.

Stock Chart

CLDX

CLDX Stock Stats

Previous Close$46.88
Open$47.78
Bid46.5 x 700
Ask48.09 x 100
Today’s Range$46.05 - $47.9
52-Week Range$14.56 - $57.20
Volume454.16K
Average Volume787.65K
Market Cap$2.15B
Beta3.02
P/E Ratio-27.2
EPS-1.70
Earnings DateNov 10, 2021

Company Description

Celldex Therapeutics Inc

Celldex Therapeutics, Inc. engages in the research, development, and commercialization of immunotherapies and other targeted biologics. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases. Its pipeline includes Varlilumab, CDX-1140, and CDX-301, and CDX-3379. The company was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.
Sector
Healthcare
Industry
Biotechnology
CEO
Anthony S. Marucci
Employees
125
ISIN
US15117B2025
Address
53 Frontage Road, Hampton, NJ, 08827, US

Financials


P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

CLDX FAQ

What was Celldex’s price range in the past 12 months?
Celldex lowest stock price was $14.56 and its highest was $57.20 in the past 12 months.
    What is Celldex’s market cap?
    Celldex’s market cap is $2.15B.
      What is Celldex’s price target?
      The average price target for Celldex is $64.20. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $68.00 ,the lowest forecast is $60.00. The average price target represents 39.02% Increase from the current price of $46.18.
        What do analysts say about Celldex?
        Celldex’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.
          When is Celldex’s upcoming earnings report date?
          Celldex’s upcoming earnings report date is Nov 10, 2021 which is in 22 days.
            How were Celldex’s earnings last quarter?
            Celldex released its earnings results on Aug 05, 2021. The company reported -$0.338 earnings per share for the quarter, beating the consensus estimate of -$0.4 by $0.062.
              Is Celldex overvalued?
              According to Wall Street analysts Celldex’s price is currently Undervalued.
                Does Celldex pay dividends?
                Celldex does not currently pay dividends.
                What is Celldex’s EPS estimate?
                Celldex’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Celldex have?
                Celldex has 46,480,000 shares outstanding.
                  What happened to Celldex’s price movement after its last earnings report?
                  Celldex reported an EPS of -$0.338 in its last earnings report, beating expectations of -$0.4. Following the earnings report the stock price went up 6.155%.
                    Which hedge fund is a major shareholder of Celldex?
                    Among the largest hedge funds holding Celldex’s share is Perceptive Advisors LLC. It holds Celldex’s shares valued at 25M.

                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis